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To the Editor,
First of all we would like to thank G.P. Currie and
D.K. Lee for their comments to our study.
Concerning the grade of BHR, we considered the
PD20 instead of the PC20/FEV1 and our classification
is based on medical–legal rules of Italian Navy. For
the same reasons, we used methacholine challenge
as it is has been decided as criterion for medical–-
legal measures.
Unfortunately, we have to disagree with them
about the concept that ARIA classification ‘‘can
allow a more robust approach to epidemiological
and pathophysiological understanding, etc’’. We
are absolutely convinced that ARIA classification
does improve the management of allergic rhinitis,
mainly concerning the link between upper and
lower airways. Moreover, first evidence of inflam-
mation persistence in allergic rhinitis has been
provided by ourselves.1 On the contrary, when we
have to perform epidemiological and pathophysio-
logical studies, the etiological classification is the
alone correct. Our methodology considered to
evaluate subjects both during and outside theee front matter & 2005 Elsevier Ltd. All rights reserv
med.2004.09.021pollen season. According to ARIA classification,
one subject may be classified as intermittent,
persistent or without disease along the year
depending on allergen exposure. How could these
patients be classified outside pollen season? In
addition, one subject may be initially intermittent
and furtherly persistent during the whole pollen
season. It is to note that seasonal is not equivalent
to intermittent and perennial to persistent!
Finally, we agree with them about the last sentence
even though we did not mention this issue in our
paper.References
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